ArticleJournal of neurological surgery. Part B, Skull base2026
Endoscopic Transsphenoidal Selective Resection of the Medial Wall of the Cavernous Sinus for the Treatment of Functional Pituitary Adenomas.
Article in Journal of neurological surgery. Part B, Skull base, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the efficacy of endoscopic transsphenoidal selective resection of the medial wall of the cavernous sinus (MWCS) for the treatment of functional pituitary adenomas (FPAs). Methods: Clinical data of fifteen patients with FPAs were retrospectively analyzed. The MWCS on the side of the tumor was surgically resected. Results: In this study of fifteen patients, endocrine remission was observed in thirteen cases (86.7%) after surgery, and tumor cells in the MWCS were found in ten (66.7%) cases. No serious postoperative complications occurred in any patient. Conclusion: For FPAs characterized as Knosp grades 0 to 3, if there is no clear pseudocapsule or normal pituitary between the tumor and the MWCS during the operation, consideration of removal of the MWCS on that side may contribute to improved postoperative remission rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.